Axel Janke | Genomics | Innovative Research Award

Innovative Research Award

Axel Janke
Goethe University Frankfurt

Axel Janke is a researcher associated with Goethe University and Senckenberg Nature Research in Germany, with research centered on evolutionary vertebrate genomics and biodiversity genomics. His documented work includes genomic approaches to vertebrate evolution, species diversity and population history. [1]

Axel Janke
Affiliation Goethe University / Senckenberg
Country Germany
Scholar ID z_6ZG6kAAAAJ
Documents 160
Citations 13,033
h-index 59
Subject Area Genomics
Event International Environmental Scientists Award

Abstract

Axel Janke’s research profile is associated with evolutionary and biodiversity genomics, particularly the genomic study of vertebrates and the processes underlying species diversification. His institutional research activities include the development and application of genomic methods for investigating biological diversity and evolutionary history. [1]

Keywords

Axel Janke; genomics; evolutionary genomics; vertebrate genomics; biodiversity; molecular evolution; population genomics; species diversification; genome analysis; conservation biology.

Introduction

Genomic research provides methods for examining evolutionary relationships, population structure and biological diversity at increasingly detailed scales. Janke’s documented academic work places these approaches within evolutionary vertebrate genomics, with applications involving mammals, birds and other organisms. [1]

Research Profile

The Senckenberg research group identifies Axel Janke as Professor and Head of the Evolutionary Vertebrate Genomics research group. Its work examines how environmental processes shape genome evolution and uses genomic and bioinformatic methods to investigate mammalian genome sequences. [1]

Research Contributions

Documented contributions include whole-genome studies of whales, bears and giraffes, alongside research addressing species boundaries, gene flow and evolutionary history. Genomic analysis has also been applied to questions concerning biodiversity and conservation. [2]

Publications

Selected publications involving Janke include studies of blue-whale and rorqual genomes, bear evolutionary history, giraffe diversification, genome assembly and southern giraffe population genomics. These publications demonstrate the application of genomic datasets to evolutionary and biodiversity questions. [2] [3]

Research Impact

The reported Google Scholar profile supplied for this article lists 160 documents, 13,033 citations and an h-index of 59. Research outputs have also supported discussions of species diversity and conservation, including genomic evidence concerning giraffe diversity. [4]

Award Suitability

For the Innovative Research Award, the documented combination of evolutionary genomics, computational analysis and biodiversity research provides relevant evidence for consideration. The profile also includes peer-reviewed research applying genomic methods to contemporary questions in evolutionary biology. [2]

Conclusion

Axel Janke’s research record reflects sustained engagement with genomics, vertebrate evolution and biodiversity. His documented publications and institutional role provide a scholarly basis for recognition within an award category focused on innovative research.

References

  1. Senckenberg Nature Research. (n.d.). Research group Evolutionary Vertebrate Genomics. Senckenberg Biodiversity and Climate Research Centre.
    https://www.senckenberg.de/en/research/institutes-overview/sbikf-institut/sbikf-ag-evolutionary-vertebrate-genomics/
  2. Senckenberg Nature Research. (n.d.). Selected research and publications of the Evolutionary Vertebrate Genomics group.
    https://www.senckenberg.de/en/research/institutes-overview/sbikf-institut/sbikf-ag-evolutionary-vertebrate-genomics/
  3. Prochotta, D., Winter, S., Fennessy, J., & Janke, A. (2024). Population genomics of the southern giraffe. Molecular Phylogenetics and Evolution, 201, 108198. DOI: 10.1016/j.ympev.2024.108198.
    https://doi.org/10.1016/j.ympev.2024.108198
  4. Google Scholar. (n.d.). Axel Janke, Scholar profile. Profile information supplied for this article.
    https://scholar.google.com/citations?user=z_6ZG6kAAAAJ&hl=en&oi=sra
  5. Prost, S., Winter, S., De Raad, J., Coimbra, R. T. F., Wolf, M., Nilsson, M. A., et al. (2020). Education in the genomics era: Generating high-quality genome assemblies in university courses. GigaScience, 9(6), giaa058. DOI: 10.1093/gigascience/giaa058.
    https://doi.org/10.1093/gigascience/giaa058
  6. Chueca, L. J., Kochmann, J., Schell, T., Greve, C., Janke, A., Pfenninger, M., & Klimpel, S. (2021). De novo genome assembly of the raccoon dog (Nyctereutes procyonoides). Frontiers in Genetics, 12, 658256. DOI: 10.3389/fgene.2021.658256.
    https://doi.org/10.3389/fgene.2021.658256

Chun Wai Mai | Cancer | Best Researcher Award

Prof. Dr. Chun Wai Mai | Cancer | Best Researcher Award

Professor, IMU University, Malaysia 🌟

Dr. Chun-Wai Mai, a highly accomplished researcher and professor from Malaysia, is devoted to understanding the mechanisms behind tumorigenesis and metastasis. With a vision to uncover the origins of cancer, Dr. Mai aims to enhance clinical prognosis and improve patient outcomes. Over the years, he has held pivotal academic and research roles, contributing significantly to oncology, stem cell biology, genomics, and drug discovery. His work embodies a commitment to advancing medical science and tackling cancer at its roots.

Profile

Orcid

Education 🎓

Dr. Chun-Wai Mai earned his PhD in Pharmaceutical Sciences (2010–2014) and Bachelor of Pharmacy degree (2005–2009) from the International Medical University (IMU) in Kuala Lumpur, Malaysia. His strong academic foundation has fueled his impactful contributions to cancer research and drug development.

Experience 🧑‍🔬

Dr. Mai is currently a Professor at the Centre for Cancer and Stem Cell Research, International Medical University. He previously served as an Associate Professor at UCSI University (2022–2025), a Postdoctoral Fellow at Shanghai Jiao Tong University School of Medicine (2020–2022), and as a Senior Lecturer (2018–2020) and Lecturer (2010–2018) at IMU. His extensive academic journey reflects his dedication to education and research excellence.

Research Interests 🔬

Dr. Mai’s research focuses on tumorigenesis, metastasis, stem cells, and drug discovery, with a keen interest in genomics and anticancer mechanisms. He is driven by the goal of developing targeted therapies to combat cancer and improve patient outcomes, particularly in addressing the challenges of drug resistance and cancer progression.

Awards 🏆

Dr. Mai is a distinguished member of esteemed organizations, including the European Association for Cancer Research and the Royal Society of Chemistry. His groundbreaking research has earned recognition in oncology and stem cell therapy, marking him as a leader in his field.

Publications 📚

Phytochemical Analysis and Biological Activities of Flavonoids and Anthraquinones from Cassia alata (Linnaeus) Roxburgh (Plants, 2025): 10.3390/plants14030362

Scoping Review of Enablers and Challenges of Implementing Pharmacogenomics Testing in Primary Care Settings (BMJ Open, 2024): 10.1136/bmjopen-2024-087064

Recent Developments in Luteolin-Loaded Nanoformulations for Enhanced Anti-Carcinogenic Activities (Sci, 2024): 10.3390/sci6040068

Revolutionizing Treatment for Nasopharyngeal Cancer with Stem Cell and Genetically Engineered Therapies (Frontiers in Immunology, 2024): 10.3389/fimmu.2024.1484535

Molecular Mechanism of Tocotrienol-Mediated Anticancer Properties: Systematic Review (Nutrients, 2023): 10.3390/nu15081854

Conclusion

Dr. Chun-Wai Mai’s outstanding academic background, impactful research contributions, and leadership in oncology and drug discovery make him an excellent candidate for the Best Researcher Award. His focus on advancing cancer therapies aligns with the award’s vision of recognizing transformative scientific contributions. By further showcasing patents, grants, and global collaborations, Dr. Mai’s profile could achieve even greater prominence in the scientific community.